Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Drugs

Results: 1-25/138

Authors: HARVEY DR STEVENS JP
Citation: Dr. Harvey et Jp. Stevens, WHAT IS THE ROLE OF CORTICOSTEROIDS IN MENINGITIS, Drugs, 50(6), 1995, pp. 945-950

Authors: WHARTENBY KA MARROGI AJ FREEMAN SM
Citation: Ka. Whartenby et al., GENE-THERAPY - CLINICAL POTENTIAL AND RELATIONSHIPS TO DRUG-TREATMENT, Drugs, 50(6), 1995, pp. 951-958

Authors: TEO KK
Citation: Kk. Teo, RISK AND MANAGEMENT OF HYPERTENSION-RELATE LEFT-VENTRICULAR HYPERTROPHY, Drugs, 50(6), 1995, pp. 959-970

Authors: CLARK WM HAZEL JS COULL BM
Citation: Wm. Clark et al., LAZAROIDS - CNS PHARMACOLOGY AND CURRENT RESEARCH, Drugs, 50(6), 1995, pp. 971-983

Authors: RAUWS EAJ VANDERHULST RWM
Citation: Eaj. Rauws et Rwm. Vanderhulst, CURRENT GUIDELINES FOR THE ERADICATION OF HELICOBACTER-PYLORI IN PEPTIC-ULCER DISEASE, Drugs, 50(6), 1995, pp. 984-990

Authors: HIRSCHL MM
Citation: Mm. Hirschl, GUIDELINES FOR THE DRUG-TREATMENT OF HYPERTENSIVE CRISES, Drugs, 50(6), 1995, pp. 991-1000

Authors: SPENCER CM GOA KL
Citation: Cm. Spencer et Kl. Goa, AMIFOSTINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL AS A RADIOPROTECTOR AND CYTOTOXIC CHEMOPROTECTOR, Drugs, 50(6), 1995, pp. 1001-1031

Authors: PATEL SS GOA KL PARSONS RS
Citation: Ss. Patel et al., DESFLURANE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND ITS EFFICACY IN GENERAL-ANESTHESIA (VOL 50, PG 742, 1995), Drugs, 50(6), 1995, pp. 1031-1031

Authors: NOBLE S MCTAVISH D
Citation: S. Noble et D. Mctavish, LEVOCABASTINE - AN UPDATE OF ITS PHARMACOLOGY, CLINICAL EFFICACY AND TOLERABILITY IN THE TOPICAL TREATMENT OF ALLERGIC RHINITIS AND CONJUNCTIVITIS, Drugs, 50(6), 1995, pp. 1032-1049

Authors: PLOSKER GL WAGSTAFF AJ
Citation: Gl. Plosker et Aj. Wagstaff, TIAPROFENIC ACID - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND USE IN THE MANAGEMENT OF RHEUMATIC DISEASES, Drugs, 50(6), 1995, pp. 1050-1075

Authors: LAROVERE MT DEFERRARI GM
Citation: Mt. Larovere et Gm. Deferrari, NEW POTENTIAL USES FOR TRANSDERMAL SCOPOLAMINE (HYOSCINE), Drugs, 50(5), 1995, pp. 769-776

Authors: RASCOL O HAIN TC BREFEL C BENAZET M CLANET M MONTASTRUC JL
Citation: O. Rascol et al., ANTIVERTIGO MEDICATIONS AND DRUG-INDUCED VERTIGO - A PHARMACOLOGICAL REVIEW, Drugs, 50(5), 1995, pp. 777-791

Authors: ESPARZA J OSMANOV S HEYWARD WL
Citation: J. Esparza et al., HIV PREVENTIVE VACCINES - PROGRESS TO DATE, Drugs, 50(5), 1995, pp. 792-804

Authors: MULLER EE ROLLA M GHIGO E BELLITI D ARVAT E ANDREONI A TORSELLO A LOCATELLI V CAMANNI F
Citation: Ee. Muller et al., INVOLVEMENT OF BRAIN CATECHOLAMINES AND ACETYLCHOLINE IN GROWTH-HORMONE HYPERSECRETORY STATES - PATHOPHYSIOLOGICAL, DIAGNOSTIC AND THERAPEUTIC IMPLICATIONS, Drugs, 50(5), 1995, pp. 805-837

Authors: ROCKOWITZ J TUNKEL AR
Citation: J. Rockowitz et Ar. Tunkel, BACTERIAL-MENINGITIS - PRACTICAL GUIDELINES FOR MANAGEMENT, Drugs, 50(5), 1995, pp. 838-853

Authors: SPENCER CM MCTAVISH D
Citation: Cm. Spencer et D. Mctavish, BUDESONIDE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN INFLAMMATORY BOWEL-DISEASE, Drugs, 50(5), 1995, pp. 854-872

Authors: HARIA M BENFIELD P
Citation: M. Haria et P. Benfield, INTERFERON-ALPHA-2A - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN THE MANAGEMENT OF VIRAL-HEPATITIS, Drugs, 50(5), 1995, pp. 873-896

Authors: HARIA M WAGSTAFF AJ
Citation: M. Haria et Aj. Wagstaff, AMLODIPINE - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN CARDIOVASCULAR-DISEASE (VOL 50, PG 560, 1995), Drugs, 50(5), 1995, pp. 896-896

Authors: GILLIS JC GOA KL
Citation: Jc. Gillis et Kl. Goa, TRETINOIN - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND USE IN THE MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA, Drugs, 50(5), 1995, pp. 897-923

Authors: NOBLE S MARKHAM A
Citation: S. Noble et A. Markham, CYCLOSPORINE - A REVIEW OF THE PHARMACOKINETIC PROPERTIES, CLINICAL EFFICACY AND TOLERABILITY OF A MICROEMULSION-BASED FORMULATION (NEORAL), Drugs, 50(5), 1995, pp. 924-941

Authors: CLANCY RL
Citation: Rl. Clancy, MUCOSAL VACCINES FOR THE PREVENTION OF INFLUENZA, Drugs, 50(4), 1995, pp. 587-594

Authors: LARON Z
Citation: Z. Laron, GROWTH-HORMONE SECRETAGOGUES - CLINICAL-EXPERIENCE AND THERAPEUTIC POTENTIAL, Drugs, 50(4), 1995, pp. 595-601

Authors: CASTAMAN G RODEGHIERO F
Citation: G. Castaman et F. Rodeghiero, CURRENT MANAGEMENT OF VON WILLEBRANDS DISEASE, Drugs, 50(4), 1995, pp. 602-614

Authors: RAWLES J
Citation: J. Rawles, GUIDELINES FOR GENERAL-PRACTITIONERS ADMINISTERING THROMBOLYTICS, Drugs, 50(4), 1995, pp. 615-625

Authors: NOBLE S FAULDS D
Citation: S. Noble et D. Faulds, SULFASALAZINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN THE TREATMENT OF RHEUMATOID-ARTHRITIS (VOL 50, PG 137, 1995), Drugs, 50(4), 1995, pp. 625-625
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>